Efficacy, acceptability, and safety of adjunctive aripiprazole in treatment-resistant depression: a...
Efficacy, acceptability, and safety of adjunctive aripiprazole in treatment-resistant depression: a meta-analysis of randomized controlled trials
About this item
Full title
Author / Creator
Luan, Shuxin , Wan, Hongquan , Zhang, Lei and Zhao, Hua
Publisher
New Zealand: Dove Medical Press Limited
Journal title
Language
English
Formats
Publication information
Publisher
New Zealand: Dove Medical Press Limited
Subjects
More information
Scope and Contents
Contents
Treatment-resistant depression (TRD) is common and potentially life-threatening in adults, and the benefits and risks of adjunctive aripiprazole in these patients remain controversial. Therefore, we conducted a meta-analysis of randomized controlled trials (RCTs) to assess the efficacy, acceptability, safety, and quality of life of adjunctive aripi...
Alternative Titles
Full title
Efficacy, acceptability, and safety of adjunctive aripiprazole in treatment-resistant depression: a meta-analysis of randomized controlled trials
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_f65d529eeb4d4fa68ca100fca1ba58fe
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f65d529eeb4d4fa68ca100fca1ba58fe
Other Identifiers
ISSN
1178-2021,1176-6328
E-ISSN
1178-2021
DOI
10.2147/NDT.S156619
